Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering (Q51493196)

5 April 2018

title

Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering (English)

1 reference

5 April 2018

0 references

0 references

1 reference

Lawrence M Title

1

1 reference

5 April 2018

Ehud Ur

2

1 reference

5 April 2018

Karen Giddens

3

1 reference

5 April 2018

Matthew J McQueen

4

1 reference

5 April 2018

Bassam A Nassar

5

1 reference

5 April 2018

publication date

1 May 2006

1 reference

5 April 2018

published in

Vascular Medicine

1 reference

5 April 2018

volume

11

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

101-109

1 reference

5 April 2018

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

cites work

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Inflammation in atherosclerosis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Adipokines, inflammation, and the endothelium in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Oral folate enhances endothelial function in hyperhomocysteinaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Folates and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

The two-period cross-over clinical trial. 1979

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Folic acid improves endothelial function in children and adolescents with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Effects of Oral Folic Acid Supplementation on Endothelial Function in Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

Influence of Folic Acid on Postprandial Endothelial Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191/1358863X06VM664OA

10.1191/1358863X06VM664OA

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

release_qzmwql3cyrdcvj776egszcqzky

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qzmwql3cyrdcvj776egszcqzky

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

5 April 2018